Acknowledgement
Authors thank Mrs. Vidyavathi for technical assistance.
References
- World Health Organization. COVID-19 dashboard [Internet]. Geneva: GAVI; 2022 [cited 2022 Sep 21]. Available from: https://www.gavi.org/covid19
- Hanson KE, Goddard K, Lewis N, et al. Incidence of Guillain-Barre syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. JAMA Netw Open 2022;5:e228879.
- Keh RY, Scanlon S, Datta-Nemdharry P, et al. COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database. Brain 2023;146:739-48. https://doi.org/10.1093/brain/awac067
- Garcia-Grimshaw M, Galnares-Olalde JA, Bello-Chavolla OY, et al. Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization: analysis of a nationwide registry of recipients of 81 million doses of seven vaccines. Eur J Neurol 2022;29:3368-79. https://doi.org/10.1111/ene.15504
- Baars AE, Kuitwaard K, de Koning LC, et al. SARS-CoV-2 vaccination safety in Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. Neurology 2023;100:e182-91. https://doi.org/10.1212/WNL.0000000000201376
- Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain-Barre syndrome associated with COVID-19 vaccination. Emerg Infect Dis 2021;27:3175-8. https://doi.org/10.3201/eid2712.211634
- Abolmaali M, Rezania F, Behnagh AK, Hamidabad NM, Gorji A, Mirzaasgari Z. Guillain-Barre syndrome in association with COVID-19 vaccination: a systematic review. Immunol Res 2022;70:752-64. https://doi.org/10.1007/s12026-022-09316-6
- Atzenhoffer M, Auffret M, Pegat A, et al. Guillain-Barre syndrome associated with COVID-19 vaccines: a perspective from spontaneous report data. Clin Drug Investig 2022;42:581-92. https://doi.org/10.1007/s40261-022-01164-4
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27 Suppl:S21-4. https://doi.org/10.1002/ana.410270707
- Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain 2014;137(Pt 1):33-43. https://doi.org/10.1093/brain/awt285
- Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 1991;14:1103-9. https://doi.org/10.1002/mus.880141111
- Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;2:750-3. https://doi.org/10.1016/S0140-6736(78)92644-2
- Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in Northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118 (Pt 3):597-605. https://doi.org/10.1093/brain/118.3.597
- Doets AY, Walgaard C, Lingsma HF, et al. International validation of the erasmus Guillain-Barre syndrome respiratory insufficiency score. Ann Neurol 2022;91:521-31. https://doi.org/10.1002/ana.26312
- Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014;3:123-8. https://doi.org/10.15171/ijhpm.2014.71
- Hasan I, Saif-Ur-Rahman KM, Hayat S, et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis. J Peripher Nerv Syst 2020;25:335-43. https://doi.org/10.1111/jns.12419
- Doets AY, Verboon C, van den Berg B, et al. Regional variation of Guillain-Barre syndrome. Brain 2018;141:2866-77. https://doi.org/10.1093/brain/awy232
- Kim JE, Min YG, Shin JY, et al. Guillain-Barre syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol 2022;12:820723.
- Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol 2021;21:452.
- Michaelson NM, Lam T, Malhotra A, Schiff ND, MacGowan DJ. Miller Fisher syndrome presenting after a second dose of Pfizer-BioNTech vaccination in a patient with resolved COVID-19: a case report. J Clin Neuromuscul Dis 2021;23:113-5. https://doi.org/10.1097/CND.0000000000000376
- Kim Y, Zhu Z, Kochar P, Gavigan P, Kaur D, Kumar A. A pediatric case of sensory predominant Guillain-Barre syndrome following COVID-19 vaccination. Child Neurol Open 2022;9:2329048X221074549.
- Malamud E, Otallah SI, Caress JB, Lapid DJ. Guillain-Barre syndrome after COVID-19 vaccination in an adolescent. Pediatr Neurol 2022;126:9-10. https://doi.org/10.1016/j.pediatrneurol.2021.10.003
- Hughes DL, Brunn JA, Jacobs J, Todd PK, Askari FK, Fontana RJ. Guillain-Barre syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl 2022;28:134-7. https://doi.org/10.1002/lt.26279
- Tutar NK, Eyigurbuz T, Yildirim Z, Kale N. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogy Sz 2021;74:286-8. https://doi.org/10.18071/isz.74.0286
- McKean N, Chircop C. Guillain-Barre syndrome after COVID-19 vaccination. BMJ Case Rep 2021;14:e244125.
- Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barre syndrome: first reported case from Qatar. Ann Med Surg (Lond) 2021;67:102540.
- Arce Galvez L, Ramirez Abadia LA, de los Reyes Guevara CA, Hernandez Orozco JF. Guillain-Barre syndrome after vaccination for COVID-19: the first report in Latin America. Neurol Perspect 2021;1:236-8. https://doi.org/10.1016/j.neurop.2021.09.002
- Maramattom BV, Krishnan P, Paul R, et al. Guillain-Barre syndrome following ChAdOx1-S/nCoV-19 vaccine. Ann Neurol 2021;90:312-4. https://doi.org/10.1002/ana.26143
- Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus 2021;13:e13426.
- Finsterer J. Exacerbating Guillain-Barre syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis 2021;2021:3619131.
- Masuccio FG, Comi C, Solaro C. Guillain-Barre syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurol Belg 2022;122:1369-71. https://doi.org/10.1007/s13760-021-01838-4
- Matarneh AS, Al-Battah AH, Farooqui K, Ghamoodi M, Alhatou M. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect. Clin Case Rep 2021;9:e04756.
- Allen CM, Ramsamy S, Tarr AW, et al. Guillain-Barre syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol 2021;90:315-8. https://doi.org/10.1002/ana.26144
- Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases 2021;24:e01143.
- Marquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barre syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology 2021;96:1052-4. https://doi.org/10.1212/WNL.0000000000011881
- Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep 2021;14:e242956.
- Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barre syndrome following COVID-19 vaccine. BMJ Case Rep 2021;14:e243629.
- Bonifacio GB, Patel D, Cook S, et al. Bilateral facial weakness with paraesthesia variant of Guillain-Barre syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry 2022;93:341-2. https://doi.org/10.1136/jnnp-2021-327027
- Censcak D, Ungermann L, Stetkarova I, Ehler E. Guillan-Barre syndrome after first vaccination dose against COVID-19: case report. Acta Medica (Hradec Kralove) 2021;64:183-6. https://doi.org/10.14712/18059694.2021.31
- Biswas A, Pandey SK, Kumar D, Vardhan H. Post coronavirus disease: 2019 vaccination Guillain-Barre syndrome. Indian J Public Health 2021;65:422-4. https://doi.org/10.4103/ijph.ijph_1716_21
- Nasuelli NA, De Marchi F, Cecchin M, et al. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci 2021;42:4747-9. https://doi.org/10.1007/s10072-021-05467-w
- Dang YL, Bryson A. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep 2021;14:e246701.
- Min YG, Ju W, Ha YE, et al. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature. J Neuroimmunol 2021;359:577691.
- Dalwadi V, Hancock D, Ballout AA, Geraci A. Axonal-variant Guillian-barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus 2021;13:e18291.
- Fukushima T, Tomita M, Ikeda S, Hattori N. A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM 2022;115:25-7. https://doi.org/10.1093/qjmed/hcab296
- Kanabar G, Wilkinson P. Guillain-Barre syndrome presenting with facial diplegia following COVID-19 vaccination in two patients. BMJ Case Rep 2021;14:e244527.
- Morehouse ZP, Paulus A, Jasti SA, Bing X. A rare variant of Guillain-Barre syndrome following Ad26.COV2.S vaccination. Cureus 2021;13:e18153.
- Bax F, Gigli GL, Belgrado E, Brunelli L, Valente M. Guillain-Barre syndrome following COVID-19 immunization: a report of two cases. Acta Neurol Belg 2022;122:1365-7. https://doi.org/10.1007/s13760-021-01798-9
- Ling L, Bagshaw SM, Villeneuve PM. Guillain-Barre syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barre syndrome. CMAJ 2021;193:E1766-9. https://doi.org/10.1503/cmaj.210947
- Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. A novel case of bifacial diplegia variant of Guillain-Barre syndrome following Janssen COVID-19 vaccination. Neurol Int 2021;13:404-9. https://doi.org/10.3390/neurolint13030040
- Kim N, Kim JH, Park JS. Guillain-Barre syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea. Neurol Sci 2022;43:1491-3. https://doi.org/10.1007/s10072-021-05849-0
- Badoiu A, Moranne O, Coudray S, Ion IM. Clinical variant of Guillain-Barre syndrome with prominent facial diplegia After AstraZeneca coronavirus disease 2019 vaccine. J Clin Neuromuscul Dis 2021;23:115-6. https://doi.org/10.1097/CND.0000000000000383
- Bouattour N, Hdiji O, Sakka S, et al. Guillain-Barre syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci 2022;43:755-61. https://doi.org/10.1007/s10072-021-05733-x
- Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barre syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci 2021;42:4401-2. https://doi.org/10.1007/s10072-021-05523-5
- Chun JY, Park S, Jung J, et al. Guillain-Barre syndrome after vaccination against COVID-19. Lancet Neurol 2022;21:117-9. https://doi.org/10.1016/S1474-4422(21)00416-6
- Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccin Immunother 2021;17:4093-6. https://doi.org/10.1080/21645515.2021.1954826
- Kripalani Y, Lakkappan V, Parulekar L, Shaikh A, Singh R, Vyas P. A rare case of Guillain-Barre syndrome following COVID-19 vaccination. Eur J Case Rep Intern Med 2021;8:002707.
- Introna A, Caputo F, Santoro C, et al. Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association? Clin Neurol Neurosurg 2021;208:106887.
- Osowicki J, Morgan H, Harris A, Crawford NW, Buttery JP, Kiers L. Guillain-Barre syndrome in an Australian State using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Ann Neurol 2021;90:856-8. https://doi.org/10.1002/ana.26218
- James J, Jose J, Gafoor VA, Smita B, Balaram N. Guillain-Barre syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series. Neurol Clin Neurosci 2021;9:402-5. https://doi.org/10.1111/ncn3.12537
- Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barre syndrome presenting as facial diplegia after COVID-19 vaccination: a case report. J Emerg Med 2021;61:e141-5. https://doi.org/10.1016/j.jemermed.2021.07.062
- Abicic A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci 2022;43:1495-7. https://doi.org/10.1007/s10072-021-05776-0
- Rao SJ, Khurana S, Murthy G, Dawson ET, Jazebi N, Haas CJ. A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine. J Community Hosp Intern Med Perspect 2021;11:597-600. https://doi.org/10.1080/20009666.2021.1954284
- da Silva GF, da Silva CF, Oliveira RE, et al. Guillain-Barre syndrome after coronavirus disease 2019 vaccine: a temporal association. Clin Exp Neuroimmunol 2022;13:92-4. https://doi.org/10.1111/cen3.12678
- Azam S, Khalil A, Taha A. Guillain-Barre syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). Am J Med Case Rep 2021;9:424-7. https://doi.org/10.12691/ajmcr-9-8-10
- Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial diplegia: a rare, atypical variant of Guillain-Barre syndrome and Ad26.COV2.S vaccine. Cureus 2021;13:e16612.
- Nagalli S, Shankar Kikkeri N. Sub-acute onset of Guillain-Barre syndrome post-mRNA-1273 vaccination: a case report. SN Compr Clin Med 2022;4:41.
- Garcia-Grimshaw M, Michel-Chavez A, Vera-Zertuche JM, et al. Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol 2021;230:108818.
- Wan MM, Lee A, Kapadia R, Hahn C. Case series of Guillain-Barre syndrome after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Neurol Clin Pract 2022;12:149-53. https://doi.org/10.1212/CPJ.0000000000001148
- Leonhard SE, Mandarakas MR, Gondim FA, et al. Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat Rev Neurol 2019;15:671-83. https://doi.org/10.1038/s41582-019-0250-9
- Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. Brain 2021;144:682-93. https://doi.org/10.1093/brain/awaa433
- Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979;110:105-23. https://doi.org/10.1093/oxfordjournals.aje.a112795
- Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol 1981;9 Suppl:31-8. https://doi.org/10.1002/ana.410090707
- Baxter R, Bakshi N, Fireman B, et al. Lack of association of Guillain-Barre syndrome with vaccinations. Clin Infect Dis 2013;57:197-204. https://doi.org/10.1093/cid/cit222
- Jaffry M, Mostafa F, Mandava K, et al. No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: a vaccine adverse event reporting system study. Vaccine 2022;40:5791-7. https://doi.org/10.1016/j.vaccine.2022.08.038
- Lahoz Fernandez PE, Miranda Pereira J, Fonseca Risso I, et al. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review. Acta Neurol Scand 2022;145:393-8. https://doi.org/10.1111/ane.13575